NEWS

GEG-tech signs Distribution Agreement with tebu-bio GEG-tech’s agreement with tebu-bio expands the distribution of advanced vectorisation systems & tools, designed by GEG-tech (genetic engineering lab) into the European Market. GEG-tech, the technology leader in advanced lentiviral vectorisation systems, announces a...Read More »

Innovation in cancerology: meeting in Monaco GEG Tech will be attending the 14th Biennale Monegasque de Cancerologie. It will take place at the end on Januray 2020 in Monaco. More than 1300 participants will be gathering and discussing the evolution...Read More »

Gene therapy : an extensive overview Recent advances in the field of genetic engineering are expanding the capability of gene therapy to treat diseases, notably those previously unreachable. As a proof, the last two years saw the number of marketing...Read More »

CAR-Based Immunotherapy We would like to share some exciting results on CAR-Based Immunotherapy. It comes from our partner Dr Oana Gavriliuc from OncoGen “Victor Babes” University of Medicine and Pharmacy, Timisoara (Romania). We are proud to introduce the poster presented...Read More »

ANCHOR Technology / Partnership We are proud to annonce you that GEG Tech has validated the combination of the ANCHOR technology developed by NeoVirTech with our Lenti-ONE vectors. This  breakthrough technology allowed us to generate the first auto-fluorescent lentiviral vectors for live imaging...Read More »